跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dobupro - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Dobupro
Approved
STANDARD
Dobupro
BCWorld Pharm. Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
27a31fe29f1c9c4d
Company
BCWorld Pharm. Co., Ltd.
Type
Standard
Approval Details
Approval Id
27a31fe29f1c9c4d
Drug Approval Philippines Name
Dobupro
Product Name
Dobupro
Registration Number
DRP-9050-03
Brand Name
Dobupro
Generic Name
Dobutamine (As Hydrochloride)
Dosage Form
Solution For Intravenous Infusion
Dosage Strength
50 mg/mL
Manufacturer
BCWorld Pharm. Co., Ltd.
Importer
JLT Pharma, Inc.
Distributor
Amediqo Phils., Inc.
Issuance Date
24 December 2021
Expiry Date
31 October 2025
Pharmacologic Category
Cardiac Stimulant (Adrenergic and Dopaminergic Agent)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
27a31fe29f1c9c4d
Type
Standard
Back to Philippines FDA Approvals